E-LIB Suche - Ergebnisse für: Htoo, Phyo T

1

Effectiveness and safety of empagliflozin: final results fr..:

Htoo, Phyo T. ; Tesfaye, Helen ; Schneeweiss, Sebastian...
Diabetologia. 67 (2024) 7 - p. 1328-1342 , 2024

Link: https://doi.org/10.1007/..

2

Correction: Cardiorenal effectiveness of empagliflozin vs. ..:

Htoo, Phyo T. ; Tesfaye, Helen ; Schneeweiss, Sebastian...
Cardiovascular Diabetology. 23 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Cardiorenal effectiveness of empagliflozin vs. glucagon-lik..:

Htoo, Phyo T. ; Tesfaye, Helen ; Schneeweiss, Sebastian...
Cardiovascular Diabetology. 23 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

4

Risk of Severe Hypoglycemia With Newer Second-line Glucose-..:

Htoo, Phyo T ; Paik, Julie M ; Alt, Ethan...
The Journals of Gerontology: Series A. 78 (2023) 12 - p. 2426-2434 , 2023

Link: https://doi.org/10.1093/..

5

Stratified analysis in comparative effectiveness studies th..:

Htoo, Phyo T. ; Glynn, Robert J. ; Wang, Shirley...
Pharmacoepidemiology and Drug Safety. 33 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

6

Evaluating Confounding Control in Estimations of Influenza ..:

Htoo, Phyo T ; Measer, Gregory ; Orr, Robert...
American Journal of Epidemiology. 191 (2022) 5 - p. 908-920 , 2022

Link: https://doi.org/10.1093/..

7

Cardiovascular Effectiveness of Sodium‐Glucose Cotransporte..:

Htoo, Phyo T. ; Buse, John ; Cavender, Matthew...
Journal of the American Heart Association. 11 (2022) 4 - p. , 2022

Link: https://doi.org/10.1161/..

8

Contributors:

, In: Pragmatic Randomized Clinical Trials,

Alamri, Khaled ; Aldridge, Molly L. ; Alphs, Larry... - p. xiii-xvi , 2021

Link: https://doi.org/10.1016/..

9

Unmeasured confounding with and without randomization:

, In: Pragmatic Randomized Clinical Trials,

Htoo, Phyo T. ; Stürmer, Til - p. 185-205 , 2021

Link: https://doi.org/10.1016/..

10

Counterpoint: Keeping the Demons at Bay When Handling Time-..:

Edwards, Jessie K ; Htoo, Phyo T ; Stürmer, Til
American Journal of Epidemiology. 188 (2019) 6 - p. 1016-1022 , 2019

Link: https://doi.org/10.1093/..

11

Effect of glucagon-like peptide-1 receptor agonists and dip..:

Htoo, Phyo T. ; Buse, John B. ; Gokhale, Mugdha...
European Journal of Clinical Pharmacology. 72 (2016) 8 - p. 1013-1023 , 2016

Link: https://doi.org/10.1007/..

12

Sodium-glucose cotransporter-2 inhibitors. vs. glucagon-lik..:

Patorno, Elisabetta ; Htoo, Phyo T ; Glynn, Robert J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969214/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Renin-Angiotensin-Aldosterone System-Based Antihypertensive..:

Htoo, Phyo T ; Stürmer, Til ; Jonsson-Funk, Michele...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768762/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Effect of Glucagon-like Peptide-1 Receptor Agonists and Dip..:

Htoo, Phyo T ; Buse, John B ; Gokhale, Mugdha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945406/. , 2016

Link: http://www.ncbi.nlm.nih...

15

Additional file 1 of Cardiorenal effectiveness of empaglifl..:

Phyo T. Htoo ; Helen Tesfaye ; Sebastian Schneeweiss...
doi:10.6084/m9.figshare.25194735.v1. , 2024

Link: https://doi.org/10.6084/..